A New Approach to Primary Ovarian Insufficiency

Obstetrics and Gynecology Clinics of North America

Volumn 39, Issue 4, 2012, Pages 567-586

  Rafique, Saima ^a   Sterling, Evelina W ^a,b   Nelson, Lawrence M ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b Project Vital Sign   (United States)

Author keywords

Infertility; Integrated care; Premature menopause; Premature ovarian failure; Primary ovarian insufficiency

Indexed keywords

25 HYDROXYVITAMIN D; FOLLITROPIN; FRAGILE X MENTAL RETARDATION PROTEIN;

ADDISON DISEASE; AGE; AMENORRHEA; ATAXIA; BONE DENSITY; CALCIUM INTAKE; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; EMOTIONAL STABILITY; EMOTIONAL STRESS; ESTROGEN THERAPY; EXERCISE; FAMILY PLANNING; FMR1 GENE; FOLLITROPIN BLOOD LEVEL; FRAGILE X SYNDROME; GYNECOLOGICAL EXAMINATION; HASHIMOTO DISEASE; HEALTH CARE POLICY; HUMAN; INTELLECTUAL IMPAIRMENT; MASLOW'S HIERARCHY OF NEEDS; MENSTRUATION DISORDER; METRORRHAGIA; MYASTHENIA GRAVIS; NUTRITIONAL ASSESSMENT; OLIGOMENORRHEA; OSTEOPOROSIS; OVARY FUNCTION; PARKINSON DISEASE; PATIENT CARE; POLYMENORRHEA; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SOCIAL ISOLATION; SOCIAL PHOBIA; SUN EXPOSURE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREMOR;

ADULT; COUNSELING; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; MENOPAUSE, PREMATURE; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PRIMARY OVARIAN INSUFFICIENCY; PROGESTINS; PROGNOSIS;

EID: 84870165928     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2012.09.007     Document Type: Review

References (120)

1. Cooper A.R., Baker V.L., Sterling E.W., et al. The time is now for a new approach to primary ovarian insufficiency. Fertil Steril 2011, 95(6):1890-1897.
2. Nelson L.M. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009, 360(6):606-614.
3. Sterling E.W., Nelson L.M. From victim to survivor to thriver: helping women with primary ovarian insufficiency integrate recovery, self-management, and wellness. Semin Reprod Med 2011, 29(4):353-361.
4. Levine S., Unutzer J., Yip J.Y., et al. Physicians' satisfaction with a collaborative disease management program for late-life depression in primary care. Gen Hosp Psychiatry 2005, 27(6):383-391.
5. Katon W.J., Lin E.H., Von Korff M., et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med 2010, 363(27):2611-2620.
6. Katon W., Russo J., Lin E.H., et al. Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial. Arch Gen Psychiatry 2012, 69(5):506-514.
7. Arora S., Geppert C.M., Kalishman S., et al. Academic health center management of chronic diseases through knowledge networks: Project ECHO. Acad Med 2007, 82(2):154-160.
8. Arora S., Thornton K., Murata G., et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 2011, 364(23):2199-2207.
9. Wenger E.C., Snyder W.M. Communities of practice: the organizational frontier. Harv Bus Rev 2000, 78:139-145.
10. Frankfurter D. A new paradigm for studying and treating primary ovarian insufficiency: the community of practice. Fertil Steril 2011, 95(6):1899-1900. [discussion: 1902].
11. Zoll K. What IF? A portrait of infertility. Available at: 2010. Accessed October 16, 2011. http://vimeo.com/11214833.
12. Wagner E.H., Austin B.T., Von Korff M. Organizing care for patients with chronic illness. Milbank Q 1996, 74(4):511-544.
13. Alzubaidi N.H., Chapin H.L., Vanderhoof V.H., et al. Meeting the needs of young women with secondary amenorrhea and spontaneous premature ovarian failure. Obstet Gynecol 2002, 99(5 Pt 1):720-725.
14. Groff A.A., Covington S.N., Halverson L.R., et al. Assessing the emotional needs of women with spontaneous premature ovarian failure. Fertil Steril 2005, 83(6):1734-1741.
15. Henry S.G. A piece of my mind. The tyranny of reality. JAMA 2011, 305(4):338-339.
16. Levinson W., Pizzo P.A. Patient-physician communication: it's about time. JAMA 2011, 305(17):1802-1803.
17. Leigh J.P., Tancredi D.J., Kravitz R.L. Physician career satisfaction within specialties. BMC Health Serv Res 2009, 9:166.
18. Lamberg L. "If I work hard(er), I will be loved." Roots of physician stress explored. JAMA 1999, 282(1):13-14.
19. Conigliaro R.L. A piece of my mind. Satisfaction?. JAMA 2005, 293(18):2193.
20. Peters H., Byskov A.G., Grinsted J. Follicular growth in fetal and prepubertal ovaries of humans and other primates. Clin Endocrinol Metab 1978, 7(3):469-485.
21. Himelstein-Braw R., Byskov A.G., Peters H., et al. Follicular atresia in the infant human ovary. J Reprod Fertil 1976, 46(1):55-59.
22. van Noord P.A., Dubas J.S., Dorland M., et al. Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors. Fertil Steril 1997, 68(1):95-102.
23. Welt C.K. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf) 2008, 68(4):499-509.
24. De Vos M., Devroey P., Fauser B.C. Primary ovarian insufficiency. Lancet 2010, 376(9744):911-921.
25. Albright F., Smith P.H., Fraser R. A syndrome characterized by primary ovarian insufficiency and decreased stature. Am J Med Sci 1942, 204:625-648.
26. Coulam C.B., Adamson S.C., Annegers J.F. Incidence of premature ovarian failure. Obstet Gynecol 1986, 67(4):604-606.
27. Rebar R.W., Connolly H.V. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990, 53(5):804-810.
28. Nelson L.M., Anasti J.N., Flack M.R. Premature ovarian failure 1996, Lippincott-Raven, Philadelphia.
29. Nelson L.M., Kimzey L.M., White B.J., et al. Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: a controlled trial. Fertil Steril 1992, 57(1):50-55.
30. Aittomaki K., Lucena J.L., Pakarinen P., et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995, 82(6):959-968.
31. Wolfsdorf J.I., Rosenfield R.L., Fang V.S., et al. Partial gonadotrophin-resistance in pseudohypoparathyroidism. Acta Endocrinol (Copenh) 1978, 88(2):321-328.
32. Yanase T., Simpson E.R., Waterman M.R. 17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 1991, 12(1):91-108.
33. Hoek A., Schoemaker J., Drexhage H.A. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997, 18(1):107-134.
34. Nelson L.M., Anasti J.N., Kimzey L.M., et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994, 79(5):1470-1475.
35. Sybert V.P., McCauley E. Turner's syndrome. N Engl J Med 2004, 351(12):1227-1238.
36. Koh J.M., Kim C.H., Hong S.K., et al. Primary ovarian failure caused by a solvent containing 2-bromopropane. Eur J Endocrinol 1998, 138(5):554-556.
37. Di Pasquale E., Beck-Peccoz P., Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 2004, 75(1):106-111.
38. Bione S., Sala C., Manzini C., et al. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet 1998, 62(3):533-541.
39. Chand A.L., Ooi G.T., Harrison C.A., et al. Functional analysis of the human inhibin alpha subunit variant A257T and its potential role in premature ovarian failure. Hum Reprod 2007, 22(12):3241-3248.
40. Toniolo D., Rizzolio F. X chromosome and ovarian failure. Semin Reprod Med 2007, 25(4):264-271.
41. Smith J.A., Vitale S., Reed G.F., et al. Dry eye signs and symptoms in women with premature ovarian failure. Arch Ophthalmol 2004, 122(2):151-156.
42. van Kasteren Y.M., Hundscheid R.D., Smits A.P., et al. Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease?. Hum Reprod 1999, 14(10):2455-2459.
43. Wittenberger M.D., Hagerman R.J., Sherman S.L., et al. The FMR1 premutation and reproduction. Fertil Steril 2007, 87(3):456-465.
44. Current evaluation of amenorrhea. Fertil Steril 2004, 82(Suppl 1):S33-S39.
45. Bakalov V.K., Anasti J.N., Calis K.A., et al. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46, XX spontaneous premature ovarian failure. Fertil Steril 2005, 84(4):958-965.
46. Novosad J.A., Kalantaridou S.N., Tong Z.B., et al. Ovarian antibodies as detected by indirect immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation. BMC Womens Health 2003, 3(1):2.
47. Rebar R.W., Erickson G.F., Yen S.S. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril 1982, 37(1):35-41.
48. Greil A.L. Infertility and psychological distress: a critical review of the literature. Soc Sci Med 1997, 45(11):1679-1704.
49. Kjaer T.K., Jensen A., Dalton S.O., et al. Suicide in Danish women evaluated for fertility problems. Hum Reprod 2011, 26(9):2401-2407.
50. Nelson L.M. One world, one woman: a transformational leader's approach to primary ovarian insufficiency. Menopause 2011, 18(5):480-487.
51. Davis M., Ventura J.L., Wieners M., et al. The psychosocial transition associated with spontaneous 46, XX primary ovarian insufficiency: illness uncertainty, stigma, goal flexibility, and purpose in life as factors in emotional health. Fertil Steril 2010, 93(7):2321-2329.
52. Shuster L.T., Rhodes D.J., Gostout B.S., et al. Premature menopause or early menopause: long-term health consequences. Maturitas 2010, 65(2):161-166.
53. Boughton M.A. Premature menopause: multiple disruptions between the woman's biological body experience and her lived body. J Adv Nurs 2002, 37(5):423-430.
54. Liao K.L., Wood N., Conway G.S. Premature menopause and psychological well-being. J Psychosom Obstet Gynaecol 2000, 21(3):167-174.
55. Wright J., Allard M., Lecours A., et al. Psychosocial distress and infertility: a review of controlled research. Int J Fertil 1989, 34(2):126-142.
56. Schmidt P.J., Cardoso G.M., Ross J.L., et al. Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. JAMA 2006, 295(12):1374-1376.
57. Orshan S.A., Furniss K.K., Forst C., et al. The lived experience of premature ovarian failure. J Obstet Gynecol Neonatal Nurs 2001, 30(2):202-208.
58. Clayton P.J. Mortality and morbidity in the first year of widowhood. Arch Gen Psychiatry 1974, 30(6):747-750.
59. Raphael B. The management of pathological grief. Aust N Z J Psychiatry 1975, 9(3):173-180.
60. Jacobs S., Hansen F., Kasl S., et al. Anxiety disorders during acute bereavement: risk and risk factors. J Clin Psychiatry 1990, 51(7):269-274.
61. Downey G., Silver R.C., Wortman C.B. Reconsidering the attribution-adjustment relation following a major negative event: coping with the loss of a child. J Pers Soc Psychol 1990, 59(5):925-940.
62. Horowitz M.J. A model of mourning: change in schemas of self and other. J Am Psychoanal Assoc 1990, 38(2):297-324.
63. Stroebe M., Stroebe W. Does "grief work" work?. J Consult Clin Psychol 1991, 59(3):479-482.
64. Prigerson H.G., Frank E., Kasl S.V., et al. Complicated grief and bereavement-related depression as distinct disorders: preliminary empirical validation in elderly bereaved spouses. Am J Psychiatry 1995, 152(1):22-30.
65. Schmidt P.J., Luff J.A., Haq N.A., et al. Depression in women with spontaneous 46, XX primary ovarian insufficiency. J Clin Endocrinol Metab 2011, 96(2):E278-E287.
66. Orshan S.A., Ventura J.L., Covington S.N., et al. Women with spontaneous 46, XX primary ovarian insufficiency (hypergonadotropic hypogonadism) have lower perceived social support than control women. Fertil Steril 2009, 92(2):688-693.
67. Covington S.N., Hillard P.J., Sterling E.W., et al. A family systems approach to primary ovarian insufficiency. J Pediatr Adolesc Gynecol 2011, 24(3):137-141.
68. Maslow A. Motivation and personality 1970, Harper & Row, New York. 2nd edition.
69. Keyes C.L., Shmotkin D., Ryff C.D. Optimizing well-being: the empirical encounter of two traditions. J Pers Soc Psychol 2002, 82(6):1007-1022.
70. McGregor I., Little B.R. Personal projects, happiness, and meaning: on doing well and being yourself. J Pers Soc Psychol 1998, 74(2):494-512.
71. Frankl V.E. From death-camp to existentialism a psychiatrist's path to a new therapy 1959, Beacon Press, Boston.
72. Domar A., Penzias A., Dusek J., et al. The stress and distress of infertility: does religion help women cope?. Sex Reprod Menopause 2005, 3:45-51.
73. Ventura J.L., Fitzgerald O.R., Koziol D.E., et al. Functional well-being is positively correlated with spiritual well-being in women who have spontaneous premature ovarian failure. Fertil Steril 2007, 87(3):584-590.
74. Gallagher J.C. Effect of early menopause on bone mineral density and fractures. Menopause 2007, 14(3 Pt 2):567-571.
75. Jacobsen B.K., Knutsen S.F., Fraser G.E. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol 1999, 52(4):303-307.
76. de Kleijn M.J., van der Schouw Y.T., Verbeek A.L., et al. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol 2002, 155(4):339-345.
77. Mondul A.M., Rodriguez C., Jacobs E.J., et al. Age at natural menopause and cause-specific mortality. Am J Epidemiol 2005, 162(11):1089-1097.
78. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288(3):321-333.
79. Mishell D.R., Nakamura R.M., Crosignani P.G., et al. Serum gonadotropin and steroid patterns during the normal menstrual cycle. Am J Obstet Gynecol 1971, 111(1):60-65.
80. Scarabin P.Y., Alhenc-Gelas M., Plu-Bureau G., et al. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol 1997, 17(11):3071-3078.
81. Scarabin P.Y., Oger E., Plu-Bureau G. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 2003, 362(9382):428-432.
82. Canonico M., Oger E., Plu-Bureau G., et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007, 115(7):840-845.
83. Gibbons W.E., Moyer D.L., Lobo R.A., et al. Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women. Am J Obstet Gynecol 1986, 154(2):456-461.
84. Bjarnason K., Cerin A., Lindgren R., et al. Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group. Maturitas 1999, 32(3):161-170.
85. van Kasteren Y.M., Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999, 5(5):483-492.
86. Pines A., Sturdee D.W., Birkhauser M.H., et al. IMS updated recommendations on postmenopausal hormone therapy. Climacteric 2007, 10(3):181-194.
87. McConkie-Rosell A., Finucane B., Cronister A., et al. Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors. J Genet Couns 2005, 14(4):249-270.
88. Sherman S., Pletcher B.A., Driscoll D.A. Fragile X syndrome: diagnostic and carrier testing. Genet Med 2005, 7(8):584-587.
89. American College of Obstetricians and Gynecologists Committee on Genetics ACOG Committee Opinion. No. 338. Screening for fragile X syndrome. Obstet Gynecol 2006, 107(6):1483-1485.
90. Popat V.B., Calis K.A., Vanderhoof V.H., et al. Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab 2009, 94(7):2277-2283.
91. North American Menopause Society The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society. Menopause 2006, 13(6):862-877. [quiz: 878-80].
92. Martyn-St James M., Carroll S. A meta-analysis of impact exercise on postmenopausal bone loss: the case for mixed loading exercise programmes. Br J Sports Med 2009, 43(12):898-908.
93. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357(3):266-281.
94. Drake M.T., Clarke B.L., Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 2008, 83(9):1032-1045.
95. Floyd R.L., O'Connor M.J., Sokol R.J., et al. Recognition and prevention of fetal alcohol syndrome. Obstet Gynecol 2005, 106(5 Pt 1):1059-1064.
96. ACOG Committee on Ethics ACOG Committee Opinion. Number 294, May 2004. At-risk drinking and illicit drug use: ethical issues in obstetric and gynecologic practice. Obstet Gynecol 2004, 103(5 Pt 1):1021-1031.
97. ACOG Committee on Health Care for Underdeserved Women, ACOG Committee on Obstetric Practice ACOG Committee Opinion. Number 316, October 2005. Smoking cessation during pregnancy. Obstet Gynecol 2005, 106(4):883-888.
98. The American Academy of Pediatrics and The American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care. 5th edition 2002, American Academy of Pediatrics, Elk Grove Village (IL).
99. Stazi A.V., Mantovani A. A risk factor for female fertility and pregnancy: celiac disease. Gynecol Endocrinol 2000, 14(6):454-463.
100. Bakalov V.K., Vanderhoof V.H., Bondy C.A., et al. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod 2002, 17(8):2096-2100.
101. Kim T.J., Anasti J.N., Flack M.R., et al. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1997, 89(5 Pt 1):777-779.
102. Baker V. Life plans and family-building options for women with primary ovarian insufficiency. Semin Reprod Med 2011, 29(4):362-372.
103. Miall C. The stigma of involuntary childlessness. Soc Probl 1986, 33:268-282.
104. Whiteford L.M., Gonzalez L. Stigma: the hidden burden of infertility. Soc Sci Med 1995, 40(1):27-36.
105. Lovett L.L. Conceiving the future: pronatalism, reproduction, and the family in the United States, 1890-1938 2007, University of North Carolina Press, Chapel Hill (NC).
106. Greil A.L., Porter K.L., Leitko T.L., et al. Why me?: theodicies of infertile women and men. Sociol Health Illn 1989, 11:213-229.
107. Becker G. Metaphors in disrupted lives: Infertility and cultural constructions of continuity. Med Anthropol Q 1994, 8:383-410.
108. Woollett A. Childlessness: strategies for coping with infertility. Int J Behav Dev 1985, 8:473-482.
109. Alper M.M., Jolly E.E., Garner P.R. Pregnancies after premature ovarian failure. Obstet Gynecol 1986, 67(Suppl 3):59S-62S.
110. Hafez E.S., Evans T.N. Human reproduction, conception and contraception 1973, Medical Dept: Harper & Row, Hagerstown (MD).
111. Silber S.J., Grudzinskas G., Gosden R.G. Successful pregnancy after microsurgical transplantation of an intact ovary. N Engl J Med 2008, 359(24):2617-2618.
112. Sauer M.V., Paulson R.J., Lobo R.A. A preliminary report on oocyte donation extending reproductive potential to women over 40. N Engl J Med 1990, 323(17):1157-1160.
113. Soderstrom-Anttila V., Tiitinen A., Foudila T., et al. Obstetric and perinatal outcome after oocyte donation: comparison with in-vitro fertilization pregnancies. Hum Reprod 1998, 13(2):483-490.
114. Salha O., Sharma V., Dada T., et al. The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum Reprod 1999, 14(9):2268-2273.
115. Krieg S.A., Henne M.B., Westphal L.M. Obstetric outcomes in donor oocyte pregnancies compared with advanced maternal age in in vitro fertilization pregnancies. Fertil Steril 2008, 90(1):65-70.
116. Keenan J., Finger R., Check J.H., et al. Favorable pregnancy, delivery, and implantation rates experienced in embryo donation programs in the United States. Fertil Steril 2008, 90(4):1077-1080.
117. Hartigan E.G., Brown D.J. Discharge planning for continuity of care. The service population. NLN Publ 1985, (20-1977):19-27.
118. Mc carthy S. Discharge planning: strategies for assuring continuity of care 1988, Aspen, Rockville (MD).
119. Moore M., Ekman E., Shumway M. Understanding the critical role of social work in safety net medical settings: framework for research and practice in the emergency department. Soc Work Health Care 2012, 51(2):140-148.
120. Galati M., Wong H.J., Morra D., et al. An evidence-based case for the value of social workers in efficient hospital discharge. Health Care Manag (Frederick) 2011, 30(3):242-246.